Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
Ligelizumab可改善慢性自发性荨麻疹患者的血管性水肿、疾病严重程度和生活质量。
期刊:World Allergy Organization Journal
影响因子:4.3
doi:10.1016/j.waojou.2022.100716
Metz, Martin; Bernstein, Jonathan A; Giménez-Arnau, Ana M; Hide, Michihiro; Maurer, Marcus; Sitz, Karl; Soong, Weily; Sussman, Gordon; Hua, Eva; Barve, Avantika; Barbier, Nathalie; Balp, Maria-Magdalena; Severin, Thomas